Cue Biopharma, Inc. (CUE)
0.4946
-0.03
(-6.38%)
USD |
NASDAQ |
Dec 09, 16:00
0.4868
-0.01
(-1.58%)
After-Hours: 20:00
Cue Biopharma EPS Diluted (Quarterly): -0.0738 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insmed, Inc. | -1.747 |
| Puma Biotechnology, Inc. | 0.1736 |
| Mersana Therapeutics, Inc. | -1.511 |
| Adaptive Biotechnologies Corp. | 0.0585 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.448M |
| Revenue (Quarterly) | 2.149M |
| Total Expenses (Quarterly) | 9.597M |
| Enterprise Value | 26.44M |
| Gross Profit Margin (Quarterly) | 96.32% |
| Profit Margin (Quarterly) | -346.6% |
| Earnings Yield | -92.11% |
| Normalized Earnings Yield | -92.14 |